Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women

Background: Controlled pharmacokinetic (PK) studies in United States populations have defined categories of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) for various pre-exposure prophylaxis (PrEP) adherence targets. It is unknown how these categories perform in other populations. Theref...

Full description

Bibliographic Details
Main Authors: Maria Pyra, Pete Anderson, Jessica E. Haberer, Renee Heffron, Connie Celum, Stephen Asiimwe, Elly Katabira, Nelly R. Mugo, Elizabeth A. Bukusi, Jared M. Baeten
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
tenofovir-diphosphate
adherence
pre-exposure prophylaxis
women
Africa
HIV
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00401/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00401/full

Similar Items